Vermillion Wealth Management’s Lifestance Health LFST Stock Holding History

Vermillion Wealth Management’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11	Closed	-$70	–	2043
2026 Q1	$70	Buy	+11	New	+$77	﹤0.01%	1478

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vermillion Wealth Management's LFST Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Lifestance Health (LFST) in Q2 2026, closing a stake of 11 shares — an estimated $70 sold.

Vermillion Wealth Management first reported a position in LFST in Q1 2026 and held it in 1 quarter. The position peaked at $70 in Q1 2026. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Vermillion Wealth Management reported no remaining Lifestance Health position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 11 Lifestance Health shares in Q2 2026, an estimated $70.
Vermillion Wealth Management first reported a position in Lifestance Health in Q1 2026 and held it in 1 quarter.
Vermillion Wealth Management's Lifestance Health position peaked at $70 in Q1 2026.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.